SpliceBio
Investments
SpliceBio Raises EUR 50M in oversubscribed Series A financing to advance protein splicing platform and expand gene therapy pipeline
SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced the completion of an oversubscribed €50 million series A financing. The financing was co-led by UCB Ventures and existing shareholder Ysios Capital and joined by new investors New Enterprise Associates (NEA), Gilde Healthcare, Novartis Venture Fund, and existing shareholder Asabys […]